Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Aldosterone
(D10528)
[1] Aldosterone[1] Aldosterone (D10528) 💬[1] NR3C2 💬[1] Aldosterone-regulated sodium reabsorption 💬[1] 222 💬
2Symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
(D10528)
[3] Aldosterone,
Angiotensin II,
Calcium
[3] Angiotensin II ,
Angiotensin II ,
Aldosterone (D10528) 💬
[3] AGTR1,
AGTR2,
NR3C2 💬
[17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 222 💬